FDA Import Refusal AEK-0935493-6/10002/1 — INTAS PHARMACEUTICALS LTD
The FDA refused shipment AEK-0935493-6/10002/1 from INTAS PHARMACEUTICALS LTD (India) on Jul 17, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 17, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75